Title:
BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME
Document Type and Number:
WIPO Patent Application WO/2018/199709
Kind Code:
A2
Abstract:
The present invention relates to a biomarker composition for diagnosis of SLE comprising AIMP1 as an active ingredient, and a method for diagnosing SLE using the same. Specifically, provided in the present invention are a biomarker composition for diagnosis of SLE comprising AIMP1, an SLE diagnosis kit using the same, and a method for diagnosing SLE. Also, provided is a biomarker composition for predicting a prognosis of SLE comprising AIMP1 as an active ingredient, a SLE prognosis prediction kit using the same, and a SLE prognosis prediction method. Therefore, the AIMP1 of the present invention can be effectively used for diagnosis and prognosis prediction of SLE.
More Like This:
Inventors:
PARK SANG GYU (KR)
LEE SANG WON (KR)
LEE SANG WON (KR)
Application Number:
PCT/KR2018/005001
Publication Date:
November 01, 2018
Filing Date:
April 30, 2018
Export Citation:
Assignee:
UNIV AJOU IND ACADEMIC COOP FOUND (KR)
International Classes:
G01N33/68; G01N33/564
Attorney, Agent or Firm:
TAEBAEK INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: